Latest News & Features
Americas
Australian ear implants manufacturer Cochlear must pay $268 million for infringing a patent owned by a US medical research organisation. 20 May 2020
Americas
Canada’s Department of Agriculture and Agri-Food has accused a Washington-based nursery, a fruit seller, and a fruit grower of infringing a plant patent covering the Staccato type of cherry tree. 20 May 2020
Americas
The US has joined consensus on a World Health Organization resolution on the global handling of the COVID-19 pandemic, but disassociated itself from the IP and reproductive health services wording within the resolution. 20 May 2020
Americas
The US government has urged a Delaware federal court to throw out patent infringement claims from Gilead Sciences over HIV prevention medicines. 19 May 2020
Africa
The World Health Organization and Costa Rica will launch a technology pooling initiative to help fight the COVID-19 pandemic. 19 May 2020
Big Pharma
Sanofi is facing criticism after CEO Paul Hudson said the US was likely to have priority access on any COVID-19 vaccine produced by the French pharmaceutical company. 15 May 2020
Big Pharma
The CJEU’s decision in Royalty Pharma has provided much-anticipated guidance on supplementary protection certificates but has left a lot of uncertainty. Was this the best the CJEU could come up with? Beatriz San Martin of Arnold & Porter reports. 15 May 2020
Plant Varieties
The European Patent Office has said that plants and animals exclusively obtained by essentially biological processes are not patentable. 14 May 2020
Big Pharma
Natera has agreed to license Illumina IP covering non-invasive prenatal testing (NIPT), in a deal that sees the pair settle all outstanding patent litigation over the technology. 14 May 2020
Generics
Gilead has agreed to license its antiviral remdesivir to five generic makers for distribution during the COVID-19 pandemic. 14 May 2020